Advanced Gastroesophageal Cancers — Expert Perspectives on Actual Patient Cases: Part 2 of 2
Oncology Today with Dr Neil Love
00:00
Other combinations: VEGF, lenvatinib, ADCs
Dr Janjigian reviews negative VEGF/lenvatinib results and evolving ADC and bispecific strategies in trials.
Play episode from 50:06
Transcript
